Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

CXCR2 in skin cells promotes tumor growth.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

A CCS patient with severe complications was successfully treated using combined therapies.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

The compound 4c showed strong potential as an anticancer agent.

5α-Reductase helps regulate hormone action in toad testes, especially during breeding season.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.